Imsol Corp.
USPTO PatentsView assignee record - 9 granted patents across 6 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene).
The verdict
According to USPTO PatentsView, Imsol ranks #29,062 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 6 technology areas.
- #29,062
- of 49,997 US assignees by volume
- 36th percentile
- by Innovation Score (31.1/100)
- 10.2
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R29062 · Foreign Corporation #29,062 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 9 grants
- MID-PACK #29,062/49,997
- PHOTO-FINISH Imedicom
- CPC-NARROW A61C · 6 areas
- INNOV-THIN 31.1/100
- CLAIMS-PAR 10.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2024 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Imedicom Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Imsol’s 31.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Imsol
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Imsol · this assignee 31
Imsol · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Imsol's Innovation Score is 31.1/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Imsol?
Each dot is one of Imsol’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Imsol’s own 10.2 claims/patent is at or below the 18.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Imsol's grants concentrate
Imsol Corp. is a focused PatentsView assignee: 6 CPC subclasses with 55.6% of grants classified under A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2022. By volume, Imsol sits between Imedicom Co., Ltd. and Incnetworks, Inc..
Imsol's three-year grant acceleration
Imsol Corp. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Imsol's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Imedicom
Imedicom Co., Ltd.
9 patents
- Immuneonco Biopha…
Immuneonco Biopharmaceuticals (SHANGHAI) Inc.
9 patents
- Immunoqure
Immunoqure AG
9 patents
- Impac Medical Sys…
Impac Medical Systems, Inc.
9 patents
- IN Ingredients
IN Ingredients, Inc.
9 patents
- In-tech Enterprise
In-tech Enterprise Ltd.
9 patents
- Inbios Internatio…
Inbios International, Inc.
9 patents
- Incnetworks
Incnetworks, Inc.
9 patents
- Imsol ◀
Imsol Corp.
9 patents
What this shows Imsol holds 9 patents at rank #29,040, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Imsol
By rank, the assignees closest to #29,040 in granted patent volume.
- Imedicom Co., Ltd. #29,036 · 9 patents
- Immuneonco Biopharmaceuticals (SHANGHAI) Inc. #29,037 · 9 patents
- Immunoqure AG #29,038 · 9 patents
- Impac Medical Systems, Inc. #29,039 · 9 patents
- IN Ingredients, Inc. #29,041 · 9 patents
- In-tech Enterprise Ltd. #29,042 · 9 patents
- Inbios International, Inc. #29,043 · 9 patents
- Incnetworks, Inc. #29,044 · 9 patents
Leaders in A61C (Dentistry)
Other assignees with the most granted patents in Imsol's primary technology class.
Imsol's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 36th percentile higher than 36% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 4 | 44.4% |
| 2022 | 1 | 11.1% |
| 2023 | 2 | 22.2% |
| 2024 | 2 | 22.2% |
Which technologies does Imsol Corp. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Imsol Corp.'s patent record in context - here's where to go next.
- Imsol Corp.'s lead technology class is A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene), 55.6% of its portfolio - see every assignee active in that class. Explore A61C
- Ranked #29,062 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Imsol Corp. against Imedicom Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.